Cor Vasa 2020, 62(6):602-608 | DOI: 10.33678/cor.2020.037

(The Role of PET/CT in Angiology)

David Zogala
Ústav nukleární medicíny, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze

The positron emission tomography combined with computer tomography (PET/CT) is a well established imag- ing modality in the oncological practice. The most frequently used radiopharmaceutical is 2-deoxy-2-(18F)fluoro-D-glucose (FDG). Due to the unspecific nature of its biodistribution high uptake of FDG reflects also increased metabolic turnover in the cells mediating inflammatory reaction. The most important role of FDG PET/CT in vascular imaging is in the detection of infection/inflammation. It is used mainly in the diagnosis of vasculitis, vascular graft infection, and inflammatory aneurysm and rarely in the diagnosis of vascular tumors. It can bring prognostic information in the evaluation of inflammatory activity (vulnerability) of atherosclerotic plaques. A review of literature and clinical experiences are presented in this review article.

Keywords: Cardiovascular inflammation, PET, PET/CT, Positron emission tomography,

Received: April 7, 2020; Revised: April 7, 2020; Accepted: May 4, 2020; Published: December 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zogala D. (The Role of PET/CT in Angiology). Cor Vasa. 2020;62(6):602-608. doi: 10.33678/cor.2020.037.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Slart RH. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 2018;7:1250-1269. Go to original source... Go to PubMed...
    2. Soussan M, Nicolas P, Schramm C, et al. Management of large--vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore) 2015;94:e622. Go to original source... Go to PubMed...
    3. Hackl G, Milosavljevic R, Belaj K, et al. The value of FDG-PET in the diagnosis of thromboangiitis obliterans - a case series. Clin Rheumatol 2015;4:739-744. Go to original source... Go to PubMed...
    4. Soussan M, Abisror N, Abad S, et al. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev 2014;2:125-131. Go to original source... Go to PubMed...
    5. Besson FL, de Boysson H, Parienti JJ, et al. Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study. Eur J Nucl Med Mol Imaging 2014;1:155-166. Go to original source... Go to PubMed...
    6. Rehak Z, Vasina J, Ptacek J, et al. PET/CT in giant cell arteritis: High (18)F-FDG uptake in the temporal, occipital and vertebral arteries. Rev Esp Med Nucl Imagen Mol 2016;6:398-401. Go to original source... Go to PubMed...
    7. Rehak Z, Vasina J, Nemec P, et al. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;4:629-636. Go to original source... Go to PubMed...
    8. Mikail N, Benali K, Dossier A, et al. Additional Diagnostic Value of Combined Angio-Computed Tomography and (18)F-Fluorodeoxyglucose Positron Emission Tomography in Infectious Aortitis. JACC Cardiovasc Imaging 2018;2:361-364. Go to original source... Go to PubMed...
    9. Einspieler I, Thurmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging 2015;7:1012-1024. Go to original source... Go to PubMed...
    10. Dellavedova L, Carletto M, Faggioli P, et al. The prognostic value of baseline (18)F-FDG PET/CT in steroid-naive large-vessel vasculitis: introduction of volume-based parameters. Eur J Nucl Med Mol Imaging 2016;2:340-348. Go to original source... Go to PubMed...
    11. Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008;8:1179-1184. Go to original source... Go to PubMed...
    12. Blockmans D, de Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;1:131-137. Go to original source... Go to PubMed...
    13. Nielsen BD, Gormsen LC, Hansen IT, et al. Three days of high- -dose glucocorticoid treatment attenuates large-vessel
    14. Yabusaki S, Oyama-Manabe N, Manabe O, et al. Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. EJNMMI Res 2017 Dec;7(1):20. doi: 10.1186/s13550-017-0268-1. Epub 2017 Feb 27. PMID: 28244022; PMCID: PMC5328898. Go to original source... Go to PubMed...
    15. Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole--body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 2011;10:1265-1275. Go to original source... Go to PubMed...
    16. Ishizaka N, Sohmiya K, Miyamura M, et al. Infected aortic aneurysm and inflammatory aortic aneurysm - in search of an optimal differential diagnosis. J Cardiol 2012;2:123-131. Go to original source... Go to PubMed...
    17. Jalalzadeh H, Indrakusuma R, Planken RN, et al. Inflammation as a Predictor of Abdominal Aortic Aneurysm Growth and Rupture: A Systematic Review of Imaging Biomarkers. Eur J Vasc Endovasc Surg 2016;3:333-342. Go to original source... Go to PubMed...
    18. F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging 2018;7:1119-1128.
    19. Berger P, Vaartjes I, Scholtens A, et al. Differential FDG-PET Uptake Patterns in Uninfected and Infected Central Prosthetic Vascular Grafts. Eur J Vasc Endovasc Surg 2015;3:376-383. Go to original source... Go to PubMed...
    20. Sah BR, Husmann L, Mayer D, et al. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg 2015;4:455-464. Go to original source... Go to PubMed...
    21. Reinders Folmer EI, Von Meijenfeldt GCI, Van der Laan MJ, et al. Diagnostic Imaging in Vascular Graft Infection: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg 2018;5:719-729. Go to original source... Go to PubMed...
    22. Spacek M, Belohlavek O, Votrubova J, et al. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging 2009;5:850-858. Go to original source... Go to PubMed...
    23. Rojoa D, Kontopodis N, Antoniou SA, et al. 18F-FDG PET in the Diagnosis of Vascular Prosthetic Graft Infection: A Diagnostic Test Accuracy Meta-Analysis. Eur J Vasc Endovasc Surg 2019;2:292-301. Go to original source... Go to PubMed...
    24. Husmann L, Ledergerber B, Anagnostopoulos A, et al. The role of FDG PET/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging 2018;11:1987-1997. Go to original source... Go to PubMed...
    25. Husmann L, Huellner MW, Ledergerber B, et al. Comparing diagnostic accuracy of (18)F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infections. Eur J Nucl Med Mol Imaging 2019;6:1359-1368. Go to original source... Go to PubMed...
    26. Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg 2005;5:919-925. Go to original source... Go to PubMed...
    27. Keidar Z, Engel A, Hoffman A, et al. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med 2007;8:1230-1236. Go to original source... Go to PubMed...
    28. Keidar Z, Nitecki S. FDG-PET in prosthetic graft infections. Semin Nucl Med 2013;5:396-402. Go to original source... Go to PubMed...
    29. Tokuda Y, Oshima H, Araki Y, et al. Detection of thoracic aortic prosthetic graft infection with 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Eur J Cardiothorac Surg 2013;6:1183-1187. Go to original source... Go to PubMed...
    30. Keidar Z, Pirmisashvili N, Leiderman M, et al. 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time. J Nucl Med 2014;3:392-395. Go to original source... Go to PubMed...
    31. Marie PY, Plissonnier D, Bravetti S, et al. Low baseline and subsequent higher aortic abdominal aneurysm FDG uptake are associated with poor sac shrinkage post endovascular repair. Eur J Nucl Med Mol Imaging 2018;4:549-557. Go to original source... Go to PubMed...
    32. Lauwers P, Van den Broeck S, Carp L, et al. The use of positron emission tomography with (18)F-fluorodeoxyglucose for the diagnosis of vascular graft infection. Angiology 2007;6:717-724. Go to original source... Go to PubMed...
    33. Bruggink JL, Glaudemans AW, Saleem BR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010;3:348-354. Go to original source... Go to PubMed...
    34. Saleem BR, Pol RA, Slart RH, et al. 18F-Fluorodeoxyglucose positron emission tomography/CT scanning in diagnosing vascular prosthetic graft infection. Biomed Res Int 2014;2014:471971. Go to original source... Go to PubMed...
    35. Saleem BR, Beukinga RJ, Boellaard R, et al. Textural features of (18)F-fluorodeoxyglucose positron emission tomography scanning in diagnosing aortic prosthetic graft infection. Eur J Nucl Med Mol Imaging 2017;5:886-894. Go to original source... Go to PubMed...
    36. Bowles H, Ambrosioni J, Mestres G, et al. Diagnostic yield of (18)F-FDG PET/CT in suspected diagnosis of vascular graft infection: A prospective cohort study. J Nucl Cardiol 2020;27:294-302. Go to original source... Go to PubMed...
    37. Puges M, Berard X, Ruiz JB, et al. Retrospective Study Comparing WBC scan and (18)F-FDG PET/CT in Patients with Suspected Prosthetic Vascular Graft Infection. Eur J Vasc Endovasc Surg 2019;6:876-884. Go to original source... Go to PubMed...
    38. Zogala D, Rucka D, Ptacnik V, et al. How to recognize stent graft infection after endovascular aortic repair: the utility of 18F-FDG PET/CT in an infrequent but serious clinical setting. Ann Nucl Med 2019;8:594-605. Go to original source... Go to PubMed...
    39. Shahidi S, Eskil A, Lundof E, et al. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg 2007;5:586-592. Go to original source... Go to PubMed...
    40. Erba PA, Leo G, Sollini M, et al. Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections. Eur J Nucl Med Mol Imaging 2014;2:357-368. Go to original source... Go to PubMed...
    41. Lee WW, So Y, Kang SY, et al. F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis and prognosis prediction of vascular tumors. Oncol Lett 2017;1:665-672. Go to original source... Go to PubMed...
    42. Moon SH, Cho YS, Noh TS, et al. Carotid FDG Uptake Improves Prediction of Future Cardiovascular Events in Asymptomatic Individuals. JACC Cardiovasc Imaging 2015;8:949-956. Go to original source... Go to PubMed...
    43. Emami H, Vucic E, Subramanian S, et al. The effect of BMS- -582949,, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Atherosclerosis 2015;2:490-496. Go to original source... Go to PubMed...
    44. Adamson PD, Vesey AT, Joshi NV, et al. Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques. Cardiovasc Diagn Ther 2015;2:150-155.
    45. Tarkin JM, Joshi FR, Evans NR, et al. Detection of Atherosclerotic Inflammation by (68)Ga-DOTATATE PET Compared to [(18)F]FDG PET Imaging. J Am Coll Cardiol 2017;14:1774-1791. Go to original source... Go to PubMed...
    46. Rondina MT, Lam UT, Pendleton RC, et al. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med 2012;12:1139-1145. Go to original source... Go to PubMed...
    47. Hess S, Frary EC, Gerke O, et al. FDG-PET/CT in venous thromboembolism. Clinical and Translational Imaging 2018;5:369-378. Go to original source...
    48. Hess S, Madsen PH, Iversen ED, et al. Efficacy of FDG PET/CT imaging for venous thromboembolic disorders: preliminary results from a prospective, observational pilot study. Clin Nucl Med 2015;1:23-26. Go to original source... Go to PubMed...
    49. Frille A, Steinhoff KG, Hesse S, et al. Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension. Medicine (Baltimore) 2016 Jun;95(25):e3976. doi: 10.1097/MD.0000000000003976. PMID: 27336898; PMCID: PMC4998336. Go to original source... Go to PubMed...
    50. Wang L, Li W, Yang Y, et al. Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study. Eur Heart J Cardiovasc Imaging 2016;10:1161-1168. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes